Transform genetic profiling with cost-effective, highly accurate sequencing

Clinical research programs require sequencing platforms that deliver high accuracy, flexible scalability, and cost-effective performance in applications such as minimal residual disease (MRD) research, comprehensive genomic profiling (CGP), cancer early detection research, and rare variant detection.  

The AVITI24™ sequencing platform provides Q40–Q50 data quality, high sensitivity, and streamlined workflows to accelerate tumor and molecular profiling while reducing operational costs and turnaround times. 

Precision and flexibility meet affordability 

Run sooner: Adjust your scale cost-efficiently with low reagent costs and dual independent flow cells that let you right-size every run for faster turnaround. 

Improve sensitivity and specificity: Increase confidence in low variant allele frequency (VAF) and reduce false positives with Cloudbreak UltraQ™, delivering Q50+ accuracy. 

Accelerate results: Reduce hands-on time with Trinity™ on-flow cell enrichment, enabling faster hybrid capture sequencing for clinical research applications. 

Increase system reliability: Depend on industry-leading instrument reliability  with personalized and responsive global support.

End-to-end workflows: Leverage our close partnerships with industry leaders in panel development and data analysis for trusted end-to-end clinical research solutions. 

Applications in clinical research

The next step in discovery